Premature stop codons in a facilitating EF-hand splice variant of CaV2.1 cause episodic ataxia type 2

https://doi.org/10.1016/j.nbd.2008.06.002Get rights and content

Abstract

Premature stop codons in CACNA1A, which encodes the α1A subunit of neuronal P/Q-type (CaV2.1) Ca2+ channels, cause episodic ataxia type 2 (EA2). CACNA1A undergoes extensive alternative splicing, which contributes to the pharmacological and kinetic heterogeneity of CaV2.1-mediated Ca2+ currents. We identified three novel heterozygous stop codon mutations associated with EA2 in an alternately spliced exon (37A), which encodes part of an EF-hand motif required for Ca2+-dependent facilitation. One family had a C to G transversion (Y1854X). A dinucleotide deletion results in the same premature stop codon in a second family, and a further single nucleotide change leads to a different truncation (R1858X) in a de novo case of EA2. Expression studies of the Y1854X mutation revealed loss of CaV2.1-mediated current. Because these mutations do not affect the alternate exon 37B, these findings reveal unexpected dependence of cerebellar function on intact exon 37A-containing CaV2.1 channels.

Introduction

The CACNA1A gene on chromosome 19p13 codes for the pore-forming α1A subunit of CaV2.1 calcium channels, also known as P/Q-type channels (Mori, 1991, Ophoff, 1996, Starr, 1991). CACNA1A undergoes extensive alternative splicing (Bourinet, 1999, Kanumilli, 2006, Mori, 1991, Ophoff, 1996, Soong, 2002, Starr, 1991, Zhuchenko, 1997) resulting in expression of several different variants of CaV2.1, which is expressed abundantly in the cell bodies and dendrites of cerebellar Purkinje and granule cells, and presynaptically throughout the nervous system. Splice variants contribute to pharmacological and biophysical differences among CaV2.1-mediated calcium currents, including but not restricted to typical P-type and Q-type behavior, as defined by sensitivity to specific toxins.

The cytoplasmic C-terminus of the CaV2.1 α1-subunit contains an EF-hand domain that has been implicated in modulation of the channel by intracellular Ca2+-calmodulin (Liang et al., 2003). It exists in two mutually exclusive forms, determined by alternative splicing of exon 37 of CACNA1A. Both exons 37A and 37B are 97 base pairs in length and are 43% and 72% homologous on the DNA and protein level, respectively. The complete EF-hand motif is encoded by exons 36 and 37 together. Inclusion of exon 37A gives rise to a channel containing the EFa variant, which has been shown to exhibit activity-dependent enhancement of Ca2+ current in response to repetitive depolarization (Chaudhuri, 2004, Chaudhuri, 2007, Dunlap, 2007). Channels containing the EFb variant, which result from inclusion of exon 37B, in contrast, exhibit Ca2+-dependent inactivation.

Heterozygous CACNA1A mutations have been associated with a wide spectrum of episodic and progressive neurological disorders. These include familial hemiplegic migraine (FHM), spinocerebellar ataxia type 6 (SCA6) and episodic ataxia type 2 (EA2), sometimes complicated by epilepsy and mild mental retardation (Baloh, 1997, Denier, 1999, Imbrici, 2004, Jouvenceau, 2001, Ophoff, 1996, Zhuchenko, 1997). EA2 is characterized by attacks of cerebellar ataxia and interictal nystagmus. Many patients have headaches during attacks, which are often diagnosed as basilar-type migraine (Baloh et al., 1997). In addition, progressive cerebellar ataxia with gait unsteadiness, limb ataxia and dysarthria can occur (Kramer et al., 1995).

Several genetic mechanisms underlie these diseases, including missense mutations in association with various phenotypes, expansion of a CAG repeat in SCA6 and premature stop codons and splice-site mutations in association with EA2. Although it is generally agreed that EA2 arises from loss of Ca2+ channel function (Guida, 2001, Jen, 2001, Jouvenceau, 2001, Wappl, 2002), it remains unclear how this leads to cerebellar incoordination (Walter et al., 2006). Here we describe the clinical and functional characteristics of three previously undescribed mutations in the CACNA1A gene, all of which give rise to premature stop codons in EFa. Heterologous expression of a cDNA containing one of these stop codons reveals a non-functional α1A subunit. Because the affected individuals are heterozygous for the mutation, which only affects splice isoforms containing exon 37A, these results argue that loss of less than 50% of CaV2.1 function is sufficient to cause ataxia. Furthermore, they suggest that neural circuits that rely on exon 37A-containing (EFa) splice variants, which exhibit Ca2+-dependent facilitation, play an important role in normal cerebellar function.

Section snippets

Methods

All available family members were interviewed, underwent neurological examination and donated blood samples. Information on deceased family members was obtained from first-degree relatives. Genomic DNA was isolated from leucocytes using standard protocols. Approval for the study was obtained from local ethics committees. Mutation detection was performed by direct sequencing of all coding exons and flanking sequences of the CACNA1A gene. Mutation carriers as well as controls were tested for the

Results

Family 1 is a four-generation pedigree of autosomal dominant EA2 with considerable clinical variation (Fig. 1). The proband, a 26-year-old male, describes recurrent attacks of ataxia with lack of coordination affecting all limbs and a staggering gait, associated with headache, nausea and vomiting, diplopia and vertigo. The attacks last between 2 and 8 h and occur twice a week. Attacks are triggered by exercise, stress or chocolate consumption. Acetazolamide was ineffective. Interictal

Discussion

Two of the nucleotide changes identified in this study give rise to the same Y1854X mutation in the CACNA1A gene. Another missense mutation causes a premature termination codon 4 residues downstream (R1858X). These are all predicted to result in loss of most of the intracellular C-terminus from the splice variant of CaV2.1 α1 that contains exon 37A, or haploinsufficiency due to NMD. However, the splice variant containing exon 37B is unaffected. The phenotype due to the R1854X mutation was

Acknowledgments

We are grateful to R. van de Ven (Dept. of Human Genetics, LUMC, The Netherlands) and C. Herd (UCL Institute of Neurology, London, UK) for their technical assistance, and to C. Larsson (Dept. of Molecular Medicine, Karolinska Institute, Stockholm, Sweden) for sending the DNA of the second family. The CACNA1A cDNA clone was a gift from M. Grabner and J. Striessnig (Institut für Biochemische Pharmakologie, Innsbruck, Austria), and the β4 and α2δ1 cDNAs were generously provided by A. Dolphin (UCL,

References (31)

  • BourinetE.

    Splicing of alpha 1A subunit gene generates phenotypic variants of P-and Q-type calcium channels

    Nat. Neurosci.

    (1999)
  • ChaudhuriD.

    Alternative splicing as a molecular switch for Ca2+/calmodulin-dependent facilitation of P/Q-type Ca2+channels

    J. Neurosci.

    (2004)
  • ChaudhuriD.

    Elementary mechanisms producing facilitation of Cav2.1 (P/Q-type) channels

    J. Gen. Physiol.

    (2007)
  • DenierC.

    High prevalence of CACNA1A truncations and broader clinical spectrum in episodic ataxia type 2

    Neurology

    (1999)
  • DunlapK.

    Calcium channels are models of self-control

    J. Gen. Physiol.

    (2007)
  • Cited by (24)

    • Identification of novel and recurrent CACNA1A gene mutations in fifteen patients with episodic ataxia type 2

      2010, Journal of the Neurological Sciences
      Citation Excerpt :

      Less frequent symptoms were epilepsy, weakness, dystonia and mental retardation [8,13,21]. Paroxysmal torticollis has already been found in association with ataxic/vertigo episodes in families with NTR [5] or TR CACNA1A mutations [2–4]. Our observation confirm the possibility of this phenotype in association with EA2 mutations and it may be of particular interest especially for paediatricians, who can suspect the diagnosis in the presence of typical episodic neurological symptoms, but also in the presence of uncommon phenotypes including torticollis and hyperhydrosis that may evolve with ageing into EA2 phenotype [22].

    View all citing articles on Scopus
    1

    Present address: Department of Internal Medicine, University of Perugia School of Medicine, Section of Human Physiology, Via del Giochetto, I-06126 Perugia, Italy.

    View full text